 combin antiischem effect thromboxan receptor antagonist SQ tissue-typ plasminogen activ thromboxane-receptor antagonist SQ adjuv therapi thrombolysi antiischem activ independ thrombolyt activ tissue-typ plasminogen activ t-pa antiischem effect SQ t-pa dose t-pa SQ cardioprotect anesthet dog circumflex coronari arteri occlus minut reperfus hour dog reperfus dose t-pa reduct plasma fibrinogen combin mg/kg mg/kg/hr SQ minut initi ischemia dose t-pa SQ infarct size left ventricular area risk vehicl control t-pa SQ combin treatment signific reduct infarct size left ventricular area risk dose t-pa SQ infarct size protect effect t-pa SQ peripher hemodynam statu differ collater reperfus blood flow group thu SQ efficaci thrombolysi t-pa turn enhanc antiischem activ SQ threshold dose